SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
研友_shuang
Lv7
173
5004 积分
2020-06-15 加入
最近求助
最近应助
互助留言
Off-the-shelf CAR-T cells could prove paradigm shifting for autoimmune diseases
1天前
已完结
Long-lasting mRNA-encoded interleukin-2 restores CD8+ T cell neoantigen immunity in MHC class I-deficient cancers
3天前
已完结
Heterogeneity in the definition of dose-limiting toxicity in phase I cancer clinical trials of molecularly targeted agents: a review of the literature
16天前
已完结
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial
1个月前
已完结
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
1个月前
已完结
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
1个月前
已完结
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
1个月前
已完结
CAR T cell combination therapies to treat cancer
1个月前
已完结
A comprehensive analysis of coagulopathy during anti-B cell maturation antigen chimeric antigen receptor-T therapy in multiple myeloma, a retrospective study based on LEGEND-2
1个月前
已完结
中国药物性肝损伤诊治指南(2023版)
1个月前
已完结
没有进行任何应助
感谢
1天前
感谢
3天前
感谢
16天前
感谢
1个月前
帮大忙了
1个月前
需要补充材料:protocol和SAP
1个月前
速度真快
1个月前
感谢
1个月前
感谢
1个月前
感谢
4个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论